Search

SV Life Sciences, the venture capital investment firm with offices in Boston, San Francisco, and London, said Wednesday afternoon that it ha named Dr. Heiner Dreismann as a new Ventuer Partners. Dr. Dreismann has previously served at Roche Group, where he was President and CEO of Roche Molecular Systems, Head of Global Business Development at Roche Diagnostics and Member of Roche's Global Diagnostic Executive Committee. SV Life Sciences has approximately $2 billion of capital under management.
posted on Wednesday, October 5, 2011

Related companies:
SV Angel

Related stories:
> SV Life Sciences Names Venture Partner
> Technology Partners Raises $300M For Cleantech, Life Sciences
> SV Life Sciences Promotes Guyer
> SV Life Sciences Hires Three
> Clarus Ventures Names New Partner

---

silicontap.com Home